FAMILIAL PARTIAL LIPODYSTROPHY
Clinical trials for FAMILIAL PARTIAL LIPODYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new FAMILIAL PARTIAL LIPODYSTROPHY trials appear
Sign up with your email to follow new studies for FAMILIAL PARTIAL LIPODYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lifeline extended for rare metabolic disorder patients
Disease control AVAILABLEThis program provides continued access to metreleptin, a hormone replacement therapy, for patients with partial lipodystrophy who previously benefited from treatment in a clinical study. The program is for patients who showed improvement in diabetes control, triglyceride levels, …
Matched conditions: FAMILIAL PARTIAL LIPODYSTROPHY
Sponsor: University of Michigan • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Extended trial tests daily hormone shot for rare fat disorder
Disease control Recruiting nowThis study is a long-term follow-up for people who completed a previous trial of metreleptin, a hormone treatment given as a daily injection under the skin. It aims to monitor the safety and continued effectiveness of the treatment over time in 24 participants with familial parti…
Matched conditions: FAMILIAL PARTIAL LIPODYSTROPHY
Phase: PHASE3 • Sponsor: Amryt Pharma • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC